- cafead   Nov 14, 2023 at 09:42: AM
via Viatris and Theravance Biopharma have reported positive data from the Phase III clinical trial of Yupelri (revefenacin) as a maintenance therapy for chronic obstructive pulmonary disease (COPD).
article source
article source